Compound ID | 1857

Update compound information

Rifabutin

Class: Rifamycin

Spectrum of activity: Gram-positive & Gram-negative
Details of activity: Inhibits bacterial DNA-dependent RNA polymerase, thus inhibiting bacterial RNA synthesis
Combined with other compounds: Yes
Propensity to select resistant mutants: Yes
Description: Semisynthetic, derived from rifamycin. Used for the treatment of tuberculosis and MAC infection in combination, also active against Acinetobacter baumannii (BV100, Phase 1 as of 2022)
Institute where first reported: Pfizer
Year first mentioned: 1975
Highest development stage: Approved by FDA in 1992
Development status: Approved, off-patent
Chemical structure(s):
Click here for structure editor
Molecular weight: 847.01
Iso. SMILES: C[C@H]1/C=C/C=C(\C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)O[C@@](C4=O)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C5=NC6(CCN(CC6)CC(C)C)N=C25)O)/C
InChI Key: AZFBLLCNOQPJGJ-VXTBVIBXSA-N
Can. SMILES: CC(C)CN1CCC2(CC1)N=C3C4=C5C6=C(C)C(=C4C(=C(C3=N2)NC(=O)/C(=C\C=C\[C@H](C)[C@@H]([C@@H](C)[C@H]([C@@H](C)[C@@H]([C@H](C)[C@H](/C=C/O[C@](C)(C5=O)O6)OC)OC(=O)C)O)O)/C)O)O
InChI: InChI=1S/C46H62N4O11/c1-22(2)21-50-18-16-46(17-19-50)48-34-31-32-39(54)28(8)42-33(31)43(56)45(10,61-42)59-20-15-30(58-11)25(5)41(60-29(9)51)27(7)38(53)26(6)37(52)23(3)13-12-14-24(4)44(57)47-36(40(32)55)35(34)49-46/h12-15,20,22-23,25-27,30,37-38,41,52-55H,16-19,21H2,1-11H3,(H,47,57)/b13-12+,20-15+,24-14-/t23-,25+,26+,27+,30-,37-,38+,41+,45-/m0/s1
External links:
PubChem link: https://pubchem.ncbi.nlm.nih.gov/compound/135415564
Guide to Pharmacology: rifabutin
Citations:
  • https://academic.oup.com/jac/article/71/7/1759/1750373
  • https://www.nature.com/articles/s41564-020-0737-6
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3290133/
  • https://www.frontiersin.org/articles/10.3389/fphar.2021.693369/full

    • AntibioticDB is supported by GARDP.

    If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

    The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.